结核分枝杆菌的ESX致病系统和EspR蛋白
被引量:1
Latest research of the ESX pathogenic system and EspR protein in mycobacterium tuberculosis
摘要
近几年,结核分枝杆菌卷土重来,再次成为威胁人类健康的致病菌之一。尽管很多ESX系统的致病因子和毒力因子被研究发现,但迄今为止,结核分枝杆菌致病机制仍然不是很清楚。EspR(Rv3849)蛋白的研究可能为结核病的预防及治疗提供新的策略。
出处
《四川生理科学杂志》
2014年第1期36-38,共3页
Sichuan Journal of Physiological Sciences
基金
四川大学"大学生创新创业训练计划"项目
参考文献30
-
1Craig Williams. Global tuberculosis control: WHO report 2011[J} fu'\jZJPH, 2012, 36(S): 497 -498.
-
2Frigui W, Bottai D. Majlessi L. et aI. Control of M. tuberculosis ES?AT-6 secretion and specific T cell recognition by PhaP[]]. PLoS Pathog , 2008. 4(2): e33.
-
3Stoop [J, Bitter W, van der Sar AM Tubercle bacilli rely on a type VII army for pathogenicity[J]. Trends Microbiol, 2012. 20(0): 477-484.
-
4Das C, Ghosh TS, Mande SS. Computational analysis of the ESX-l region of Mycobacterium tuberculosis : insights into the mechanism of type VII secretion system[J]. PloS One, 2011, 6(11): e27980.
-
5Gey van Pittius NC, Sampson SL, Lee H, et aI. Evolution and ex?pansion of the Mycobacterium tuberculosis PE and PPE multigene families and their association with the duplication of the ESAT-6 (esx) gene cluster regions[J]. BMC Evol Biol, 2006, 6: 9S.
-
6Abdallah AM, Verboom T, Weerdenburg [M, et al. PPE and PE_ PGRS proteins of Mycobacterium marinum are transported via the type VII secretion system ESX-S[J]. Mol Microbiol, 2009, 73(3): 329-340.
-
7Champion PA, Champion MM, Manzanillo P. et al. ESX-l secreted virulence factors are recognized by multiple cytosolic MA ATPases in pathogenic mycobacteria[J} Mol Microbiol. 2009, 73(S): 950- 962.
-
8Carlsson F, Joshi SA, Rangell L. et al. Polar localization of viru?lence-related Esx-1 secretion in mycobacteria[J]. PLoS Pathog , 2009. S (1): el000285.
-
9Sani M. Houben EN. Geurtsen J, et al. Direct visualization by cryo-Elvl of the mycobacterial capsular layer: a labile structure con?taining ESX-l-secreted proteins[J]. PLoS Pathog , 2010. 6 (3): el000794.
-
10Millington KA. Fortune SM, Low J. et al. Rv361Sc is a highly im?munodominant RDI (Region of Difference 1 )-dependent secreted antigen specific for Mycobacterium tuberculosis infection[]J. Proc Natl Acad Sci USA. 2011. 108(4): 5730-5735.
二级参考文献20
-
1World Health Organization. Global tuberculosis control: surveillance, planning, financing: WHO report 2008 [R]. Geneva: WHO, 2008 :393.
-
2Behr MA, Wilson MA, Gill WP, et al. Comparative ge- nomics of BCG vaccines by whole-genome DNA microar ray[J]. Science, 1999,284(5419) : 1520-1523.
-
3Tan T, Lee WL, Alexander DC, et al. The ESAT-6/ CFP-10 secretion system of mycobacterium marinum modulates phagosome maturation[J]. Cellular Microbiol- ogy,2006,8(9) :1417-1429.
-
4Stanley SA,Raghavan S, Hwang WW, et al. Acute infec-tion and macrophage subversion by mycobacterium tuber- culosis require a specialized secretion system [J]. Proc Natl Acad Sci ,2003,100(22) :13001-13006.
-
5Ganguly N,Siddiqui I, Sharma P. Role of M. tuberculosis RD-1 region encoded secretory proteins in protective re- sponse and virulence[J]. Tuberculosis, 2008,88 (6) : 510- 517.
-
6Abdallah A, Geyvan PN, Champion P, et al. Type Ⅶ se- cretion mycobacteria show the way[J]. Nat Rev Microbi- ol,2007,5(11):883-891.
-
7Brodin P,Maj!essi L,Marsollier L,et al. Dissection of ES- AT-6 system 1 of mycobacterium tuberculosis and impact on immunogenicity and virulence[J]. Infect Immun,2006, 74:88-98.
-
8Raghavan S, Manzanillo P, Chan K, et al. Secreted tran- scription factor controls mycobacterium tuberculosis viru- lence[J]. Nature,2008,454(7205) :717-721.
-
9Wang S, EngohangNdong J, Smith I. Structure of the DNA- binding domain of the response regulator PhoP from myco- bacterium tuberculosis [J]. Biochemistry, 2007, 46 : 14751- 14761.
-
10Liu J, Tran V, Leung AS, et al. BCG vaccines : their mechanisms of attenuation and impact on safety and protective efficacy[J]. Hum Vaccin,2009,5(2) :70-78.
共引文献3
-
1辛田田,黎友伦.结核潜伏感染诊断方法新进展与临床应用[J].中国人兽共患病学报,2013,29(4):403-407. 被引量:12
-
2曹元应,房功思,孟德娣,汪学龙.结核分枝杆菌PPE68基因真核表达载体的构建、表达和鉴定[J].蚌埠医学院学报,2014,39(3):288-290.
-
3李双双,李木楠,关松磊,张文慧,张林波.结核分枝杆菌Rv3872与Rv3873基因的克隆及重组真核表达载体的构建[J].安徽农学通报,2017,23(8):12-15.
同被引文献7
-
1陈飞,高艳锋,朱宇皇,祁元明.结核分枝杆菌耐药相关药物外排抗原HLA-A2限制性细胞毒性T淋巴细胞表位预测[J].郑州大学学报(医学版),2011,46(6):839-841. 被引量:1
-
2杨新婷,杨扬,杜凤娇,卜建玲,梁清涛,李琦,陈效友.肺结核患者全血γ干扰素释放试验影响因素的探讨[J].中国防痨杂志,2013,35(12):1007-1012. 被引量:24
-
3王海霞,孙燕妮,王甦民,赵亭,平国玲,张力平.结核分枝杆菌Rv0440 CTL表位肽的免疫原性研究[J].中国人兽共患病学报,2014,30(5):489-493. 被引量:2
-
4赵红梅,张放.结核分枝杆菌特异性抗原检测在临床诊断中的意义[J].中国卫生标准管理,2015,6(1):36-37. 被引量:5
-
5张子胜.7种实验方法诊断结核病的临床应用价值[J].中国卫生标准管理,2016,7(9):163-164. 被引量:1
-
6唐晓萌,王大成.结核分枝杆菌ESX-1分泌蛋白EspB结构和功能分析[J].生物化学与生物物理进展,2017,44(5):414-421. 被引量:7
-
7刘振华,孙妍,夏凡,张舒林.ESAT-6/CFP-10/Rv3425/Rv3248c辅助诊断结核病的初探[J].现代免疫学,2017,37(3):188-191. 被引量:3
-
1黄艳梅,周帅,陈吟霜,谢永强,龙燕,邓秋莲,杨镒宇,周珍文.金黄色葡萄球菌EsxA基因的克隆及表达[J].热带医学杂志,2015,15(6):728-730. 被引量:5
-
2杜鸿,张萍,沈海英,王敏,戴晓莉.金黄色葡萄球菌EsxB蛋白的表达、纯化及应用[J].中华预防医学杂志,2012,46(4):364-366. 被引量:2
-
3李素华,钟森.结核杆菌保护性抗原研究现状[J].国外医学(预防.诊断.治疗用生物制品分册),2005,28(2):54-58. 被引量:2
-
4曾昭勋,尹承慧,邱俊钦,陈宗雄.人转化生长因子β1基因重组腺病毒的构建与鉴定[J].中国组织工程研究,2012,16(41):7728-7732.
-
5贺军成.入夏,谨防蜱虫卷土重来[J].家庭医药(就医选药),2011(7):73-73.
-
6孙立梅.埃博拉 会不会卷土重来[J].大众医学,2014,0(10):18-19.
-
7郝牧,左丽.登革病毒重要蛋白及其结构差异与致病性关系[J].国外医学(流行病学.传染病学分册),2003,30(5):297-301.
-
8何礼贤,邵长周.SRAS会卷土重来吗?[J].内科理论与实践,2007,2(4):214-216.
-
9熊思东.抗病毒感染的固有免疫机制[J].现代免疫学,2011,31(3):179-180. 被引量:9
-
10赵海,朱虹,宋立华,何君,檀华,端青.结核分枝杆菌ESXB-ESXA融合蛋白的表达及其作为检测抗原的初步应用[J].生物技术通讯,2010,21(4):501-504. 被引量:1